Intraoperative Video Laryngoscopy as Adjunct for Nerve Monitoring
IOVL
1 other identifier
interventional
125
1 country
5
Brief Summary
The purpose of this study is to describe the impact of adding intraoperative video laryngoscopy (IOVL) to intraoperative laryngeal nerve monitoring (IOLNM) during neck procedures when IOLNM is routinely used, including thyroidectomy and re-operative parathyroidectomy. Specifically, the study team seeks to assess how frequently the use of IOVL provided confirmatory or additional information that may affect surgeon decision-making when IOLNM alone is ambiguous, or when there is equipment malfunction or failure. The IOVL is a disposable, otherwise standard fiberoptic laryngoscope (Larynxview, Neurovision Medical, Ventura CA) that is inserted alongside the endotracheal tube following intubation for surgical procedures. It allows assessment of vocal cord movement in response to nerve stimulation. Currently, the use of IOLNM is based on audio cues, and visual assessment of external laryngeal muscle movement during surgery in response to stimulation, but no direct assessment of vocal cord movement is routinely possible. This information can be ambiguous and subject to judgement of the surgeon. The addition of IOVL provides direct assessment to vocal cord movement in response to stimulus, and may be useful in light of ambiguous IOLNM data, or limited visualization of external laryngeal muscles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 17, 2018
CompletedFirst Submitted
Initial submission to the registry
November 12, 2018
CompletedFirst Posted
Study publicly available on registry
November 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 18, 2022
CompletedResults Posted
Study results publicly available
October 2, 2023
CompletedOctober 2, 2023
August 1, 2023
3.3 years
November 12, 2018
August 18, 2023
September 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of Congruence of Nerve Integrity and Vocal Cord Functions
Frequency of congruence - IOVL used in conjunction with routine intraoperative nerve monitoring to provide additional data on nerve integrity and vocal cord functions for patients undergoing neck procedures that place the recurrent and superior laryngeal nerves at risk for injury or postoperative dysfunction. Video-captured vocal cord movement as well as the Nerveana Power Index (NPI) audio signal were recorded. Loss of signal was considered any NPI value \<100, which corresponds to loss of audio signal. The NPI is specific to the Nerveana machine, and is an index of the nerve/muscle response power (or area under the curve) as a percentage of the threshold level of response. Thus, positive EMG signal (EMG+) was an NPI value \>100. Positive IOVL (IOVL+) correlated with observed vocal cord movement on nerve stimulation; negative IOVL indicated no visible vocal cord movement. Discordances were considered to be contradictory IOVL and EMG (e.g., IOVL+ EMG-) findings for a particular nerve.
up to 3 months post-resection
Study Arms (1)
Intraoperative Video Laryngoscopy
EXPERIMENTALParticipants undergoing neck procedures
Interventions
The IOVL is a disposable, otherwise standard fiberoptic laryngoscope that is inserted alongside the endotracheal tube following intubation for surgical procedures.
Eligibility Criteria
You may qualify if:
- Age 18 and older with capacity to make all medical decisions
- Medical indication for partial or total thyroidectomy, re-operative parathyroidectomy, or neck dissection
You may not qualify if:
- Patients who are under the age of 18
- Patients who are not able to make medical decisions or consent to research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Icahn School of Medicine at Mount Sinailead
- NeuroVisioncollaborator
Study Sites (5)
Mount Sinai Queens
Long Island City, New York, 11102, United States
Mount Sinai Beth Israel
New York, New York, 10003, United States
Mount Sinai West
New York, New York, 10019, United States
Mount Sinai St. Luke's
New York, New York, 10025, United States
The Mount Sinai Hospital
New York, New York, 10029, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. David Steinmetz
- Organization
- Icahn School of Medicine at Mount Sinai
Study Officials
- PRINCIPAL INVESTIGATOR
Randall Owen, MD
Icahn School of Medicine at Mount Sinai
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 12, 2018
First Posted
November 15, 2018
Study Start
October 17, 2018
Primary Completion
January 18, 2022
Study Completion
January 18, 2022
Last Updated
October 2, 2023
Results First Posted
October 2, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share